Analyzing Enliven Therapeutics Inc (ELVN) After Recent Trading Activity
Enliven Therapeutics Inc’s recently made public that its Officer Hohl Benjamin acquired Company’s shares for reported $11848.0 on Sep 30
Enliven Therapeutics Inc’s recently made public that its Officer Hohl Benjamin acquired Company’s shares for reported $11848.0 on Sep 30
Enliven Therapeutics Inc’s recent filing unveils that its Director Heyman Richard A. unloaded Company’s shares for reported $28458.0 on Sep
Enliven Therapeutics Inc’s recent filing unveils that its CHIEF SCIENTIFIC OFFICER Lyssikatos Joseph P unloaded Company’s shares for reported $0.27
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.